Nan Fung Group
Hong Kong SARnanfung.com
Overview
Nan Fung Group is a privately held conglomerate headquartered in Hong Kong with global interests in real estate development and investment, which holds a well-diversified and substantial financial investment portfolio . The group's core business is property development in Greater China, as well as shipping, textiles and financial services . The group is also involved in international projects as sole investor or as a joint venture partner in major cities around the world and diversifies in businesses such as property construction, property management, property finance, hotel and the shipping industries .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Asian University Basketball League | Apr 2026 | Series A | Co-investor |
| BioAge Labs | Feb 2024 | Series D | - |
| Arkuda Therapeutics | Feb 2022 | Series B | Lead |
| Aboz Pharmaceuticals | Nov 2021 | Series A | - |
| HotSpot Therapeutics | Nov 2021 | Series C | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.